CALGARY, April 26 /CNW/ - Edmonton-based company, Ceapro Inc. (CZO - TSX Venture) today announced an agreement with AVAC Ltd. for an approved investment of up to $362,250 in Ceapro's product innovation project for veterinary therapeutics and personal care active ingredients based on Alberta cereal grains. The AVAC investment will enable Ceapro to further advance its commercialization project for this new technology. AVAC has provided previous investments in other Ceapro projects including beta glucan and other oat extracts, and is continuing to support the Company's products with this additional financing to expand Ceapro's product lines through successful commercialization. "We are appreciative of AVAC's continued support for new product ventures," said Dr. Mark Redmond, President and CEO of Ceapro Inc. "AVAC's financial support has been instrumental in moving our business through the early stages of development and this new investment enables us to accelerate our product development for use in cosmetics, personal care, and veterinary therapeutics." Mike Leslie, Investment Manager with AVAC, stated, "There are great things ahead for Ceapro. AVAC is very excited to be able to invest in the expansion of an Alberta venture with international commercialization opportunities that support value added agriculture in Alberta. It is a perfect fit." About Ceapro Inc. Ceapro Inc., an innovation-driven biotechnology company, develops and commercializes organic products for medical, cosmetic, and animal health industries using proprietary technology and natural, renewable resources. Based in Edmonton, Alberta, Ceapro is one of Alberta Venture's Fastest Growing Companies for 2004 and 2005 and is one of Profit Magazine's Next 100 Companies. Ceapro is also the recipient of the ASTech Award for Outstanding Commercial Achievement for companies with annual sales of less than $25 million. Ceapro will release its 2004 financial results on or before April 29, 2005. The Company's annual report, containing Management's Discussion and Analysis and Audited Financial Statements, will be mailed to shareholders on or about May 2, 2005. Ceapro's annual and special meeting of shareholders will be held on Wednesday, June 1, 2005. Ceapro's shares trade on the TSX Venture Exchange under the symbol CZO. Shares Outstanding: 36,355,950, Recent Close: $0.30. About AVAC Ltd. AVAC Ltd is a not-for-profit company dedicated to unleashing value-added innovation in Alberta. AVAC supports ideas and projects that add value to agricultural products and invest through coaching, knowledge, contacts and financial resources. AVAC's mission is to build the economic viability of Alberta's agrivalue and renewable resource ventures. Created in 1997, AVAC has to date committed over $32.9 million to agrivalue initiatives. To learn more about AVAC, visit www.avacltd.com. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this news release. This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. %SEDAR: 00010110E
Ceapro receives further investment from AVAC Ltd.
Earlier from Ceapro
Later from Ceapro
- Ceapro announces 2004 financial results
- Ceapro to present at BioFinance conference
- Ceapro Announces Highlights of Today's Annual General and Special Meeting
- Ceapro announces officer appointment
- Ceapro Announces Granting of Stock Options
Follow Ceapro into a list and get an email when it puts out news.
Follow Ceapro